Skip to content

Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules

Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03057925
Enrollment
60
Registered
2017-02-20
Start date
2017-07-01
Completion date
2018-12-31
Last updated
2017-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Nodule

Keywords

thyroid nodule, microwave ablation

Brief summary

Percutaneous microwave ablation(MWA) was reported as an effective modality for the management of thyroid nodules(TNs). This study aims to validate MWA as a feasible approach for patients with TNs for whom surgery is contraindicated or refused. Two groups of subjects with TNs(one group to treat with MWA and the other group to receive regular ultrasonic follow-up without any treatment) will be evaluated in term of TN volume, ultrasonic image and clinical symptoms.

Interventions

DEVICEMicrowave Ablation

Ultrasound-guided Percutaneous Microwave Ablation

Sponsors

First Affiliated Hospital of Wenzhou Medical University
CollaboratorOTHER
Wenjun Wu
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age\>18 years * benign thyroid nodules(TYP 2) * solid or predominantly solid(colloid component\<30%)large (\>3.0ml) thyroid nodules * refusal and/or inefficacy of surgery

Exclusion criteria

* pregnancy * malignant or suspicious thyroid nodules

Design outcomes

Primary

MeasureTime frameDescription
Change of the thyroid nodule volume assessed by ultrasonography after treatment vs simple clinical observationFrom time to treatment until 12 months. Time point evaluations at 1,3,6,12 monthsChange of the thyroid nodule volume assessed by using ultrasonography, the volume reduction ratio(VRR) was calculated by the equation: VRR%=\[(initial volume-final volume)\*100\]/initial volume

Secondary

MeasureTime frameDescription
Improved score on TN-related symptomsFrom time to treatment until 12 months. Time point evaluations at 1,3,6,12 monthsEvaluation of TN-related neck symptoms scored separately as follow:0(absent),1(moderate),2(severe). The sum of the individual scores generates a final score(SYS score) ranging from 0 to 6
Improved cosmetic grading scoreFrom time to treatment until 12 months. Time point evaluations at 1,3,6,12 monthsCosmetic problem evaluated by grading score(1,no palpable mass;2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem

Countries

China

Contacts

Primary ContactZimiao Chen
zimiaochen@163.com86-0577-88069715

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026